Effect of 0.9% NaCl compared to plasma-lyte on biomarkers of kidney injury, sodium excretion and tubular transport proteins in patients undergoing primary uncemented hip replacement - a randomized trial

A M Østergaard, A N Jørgensen, S Bøvling, N P Ekeløf, F H Mose, J N Bech, A M Østergaard, A N Jørgensen, S Bøvling, N P Ekeløf, F H Mose, J N Bech

Abstract

Background: Isotonic saline (IS) is widely used to secure perioperative cardiovascular stability. However, the high amount of chloride in IS can induce hyperchloremic acidosis. Therefore, IS is suspected to increase the risk of acute kidney injury (AKI). Biomarkers may have potential as indicators.

Methods: In a double-blinded, placebo-controlled study, 38 patients undergoing primary uncemented hip replacement were randomized to IS or PlasmaLyte (PL). Infusion was given during surgery as 15 ml/kg the first hour and 5 ml/kg the following two hours. Urinary samples were collected upon admission and the day after surgery. As surgery was initiated, urine was collected over the course of 4 h. Hereafter, another urine collection proceeded until the morning. Urine was analyzed for markers of AKI neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1). Arterious and venous blood samples for measurements of pH and plasma electrolytes including chloride (p-Cl) were collected as surgery was initiated, at the end of surgery and the following morning.

Results: IS induced an increase in p-Cl (111 ± 2 mmol/L after IS and 108 ± 3 after PL, p = 0.004) and a decrease in pH (7.39 ± 0.02 after IS and 7.43 ± 0.03 after PL, p = 0.001). Urinary NGAL excretion increased in both groups (ΔNGAL: 5.5 [4.1; 11.7] μg/mmol creatinine p = 0.004 after IS vs. 5.5 [2.1;9.4] μg/mmol creatinine after PL, p < 0.001). No difference was found between the groups (p = 0.839). Similarly, urinary KIM-1 excretion increased in both groups (ΔKIM-1: IS 115.8 [74.1; 156.2] ng/mmol creatinine, p < 0.001 vs. PL 152.4 [120.1; 307.9] ng/mmol creatinine, p < 0.001). No difference between the groups (p = 0.064). FENa increased (1.08 ± 0.52% after IS and 1.66 ± 1.15% after PL, p = 0.032). ENaC excretion was different within groups (p = 0.019).

Conclusion: A significantly higher plasma chloride and a lower pH was present in the group receiving isotonic saline. However, u-NGAL and u-KIM-1 increased significantly in both groups after surgery despite absence of changes in creatinine. These results indicate that surgery induced subclinical kidney injury. Also, the IS group had a delayed sodium excretion as compared to the PL group which may indicate that IS affects renal sodium excretion differently from PL.

Trial registration: ClinicalTrials.gov Identifier: NCT02528448 , 19/08/2015.

Keywords: Acute kidney injury; Hyperchloremic acidosis; Isotonic saline; KIM-1; NGAL.

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart showing the participant flow through screening, inclusion and completion of the trial
Fig. 2
Fig. 2
Effect of Isotonic saline vs. PlasmaLyte on arterial blood gas levels of chloride (a) and pH (b) in a double-blinded, placebo-controlled study of 38 patients. Blood samples were drawn before anesthesia (baseline), right after surgery (after surgery) and in the morning of the postoperative day (postoperative day). Values are shown as means ± SD. Statistics are performed with unparried t-test to test difference in response between treatments, † = p < 0.05. Paired t-test was used to test statistical significant difference from baseline, * = p < 0.05
Fig. 3
Fig. 3
Change from baseline in urinary excretion rate of neutrophil gelatinase-associated lipocalin (NGAL) (a) and kidney injury molecule-1 (KIM-1) (b) in a double-blinded, placebo-controlled study of 38 patients. Values represent changes form baseline to surgery, post-surgery and discharge. The increase in u-NGAL and u-KIM-1 after isotonic saline and PlasmaLyte was observed in this period. Values are shown as medians with 25 and 75 percentiles in brackets. P-value represents difference from baseline, * = p < 0.05. Statistics are performed with a Wilcoxon signed rank test
Fig. 4
Fig. 4
Effect of Isotonic saline vs. PlasmaLyte on urine output in a double-blinded, placebo-controlled study of 38 patients. Urine was collected as a 24-h urine collection (baseline) prior to surgery. As surgery was initiated urine was collected over the course of 4 h (surgery). Hereafter, another urine collection proceeded until the following morning at 8.00 am (post-surgery). Values are shown as means ± SD. Statistics are performed with unpaired t-test to test difference in response between treatments, † = p < 0.05. Paired t-test was used to test statistical significant difference from baseline, * = p < 0.05
Fig. 5
Fig. 5
Change from baseline in urinary excretion rate of ENaCγ in a double-blinded, placebo-controlled study of 38 patients. Values represent changes form baseline to surgery, post-surgery and discharge. Values are shown as means ± SD. Data are shown as means ± SD. Statistics are performed with unpaired t-test to test difference in response between treatments, † = p < 0.05. Paired t-test was used to test statistical significant difference from baseline, * = p < 0.05
Fig. 6
Fig. 6
Effect of Isotonic saline vs. PlasmaLyte on fractional excretion of sodium (FENa) in a double-blinded, placebo-controlled study of 38 patients. Urine was collected as a 24-h urine collection (baseline) prior to surgery. As surgery was initiated urine was collected over the course of 4 h (surgery). Hereafter, another urine collection proceeded until the following morning at 8.00 am (post-surgery). Values are shown as means ± SD Data are shown as means ± SD. Statistics are performed with unpaired t-test to test difference in response between treatments, † = p < 0.05. Paired t-test was used to test statistical significant difference from baseline, * = p < 0.05

References

    1. Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, et al. Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ. 2013;346:f839. doi: 10.1136/bmj.f839.
    1. Perner A, Gordon AC, De Backer D, Dimopoulos G, Russell JA, Lipman J, et al. Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy. Intensive Care Med. 2016;42(12):1958–1969. doi: 10.1007/s00134-016-4577-z.
    1. Yunos NM, Bellomo R, Glassford N, Sutcliffe H, Lam Q, Bailey M. Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis. Intensive Care Med. 2015;41(2):257–264. doi: 10.1007/s00134-014-3593-0.
    1. Barker ME. 0.9% saline induced hyperchloremic acidosis. J Trauma Nurs. 2015;22(2):111–116. doi: 10.1097/JTN.0000000000000115.
    1. Self WH, Semler MW, Wanderer JP, Wang L, Byrne DW, Collins SP, Slovis CM, Lindsell CJ, Ehrenfeld JM, Siew ED, Shaw AD, Bernard GR, Rice TW, SALT-ED Investigators Balanced crystalloids versus saline in noncritically ill adults. N Engl J Med. 2018;378(9):819–828. doi: 10.1056/NEJMoa1711586.
    1. Yunos NM, Bellomo R, Taylor DM, Judkins S, Kerr F, Sutcliffe H, et al. Renal effects of an emergency department chloride-restrictive intravenous fluid strategy in patients admitted to hospital for more than 48 hours. Emerg Med Australas. 2017;29(6):643–649. doi: 10.1111/1742-6723.12821.
    1. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71(3):726–735. doi: 10.1172/JCI110820.
    1. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18–24. doi: 10.1097/SLA.0b013e318256be72.
    1. Bullivant EM, Wilcox CS, Welch WJ. Intrarenal vasoconstriction during hyperchloremia: role of thromboxane. Am J Phys. 1989;256(1 Pt 2):F152–F157.
    1. Oczachowska-Kulik AE, Ejlersen JA, Jensen JJ, Malmberg MH, Bech JN. Effects of low chloride versus high chloride infusion on glomerular filtration rate and renal plasma flow in healthy volunteers—a randomized, controlled, Crossover Study. Open J Nephrol. 2020;10(02):73–84. doi: 10.4236/ojneph.2020.102009.
    1. Bandak G, Kashani KB. Chloride in intensive care units: a key electrolyte. F1000Res. 2017;6:1930. doi: 10.12688/f1000research.11401.1.
    1. Yessayan L, Neyra JA, Canepa-Escaro F, Vasquez-Rios G, Heung M, Yee J. Effect of hyperchloremia on acute kidney injury in critically ill septic patients: a retrospective cohort study. BMC Nephrol. 2017;18(1):346. doi: 10.1186/s12882-017-0750-z.
    1. Shao M, Li G, Sarvottam K, Wang S, Thongprayoon C, Dong Y, Gajic O, Kashani K. Dyschloremia is a risk factor for the development of acute kidney injury in critically ill patients. PLoS One. 2016;11(8):e0160322. doi: 10.1371/journal.pone.0160322.
    1. Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E, Akhter SA, Raman J, Jeevanandam V, O'Connor MF, Devarajan P, Bonventre JV, Murray PT. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010;5(12):2154–2165. doi: 10.2215/CJN.00740110.
    1. Chen LX, Koyner JL. Biomarkers in acute kidney injury. Crit Care Clin. 2015;31(4):633–648. doi: 10.1016/j.ccc.2015.06.002.
    1. Beker BM, Corleto MG, Fieiras C, Musso CG. Novel acute kidney injury biomarkers: their characteristics, utility and concerns. Int Urol Nephrol. 2018;50(4):705–713. doi: 10.1007/s11255-017-1781-x.
    1. Klein SJ, Brandtner AK, Lehner GF, Ulmer H, Bagshaw SM, Wiedermann CJ, Joannidis M. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2018;44(3):323–336. doi: 10.1007/s00134-018-5126-8.
    1. Moledina DG, Parikh CR. Phenotyping of acute kidney injury: beyond serum creatinine. Semin Nephrol. 2018;38(1):3–11. doi: 10.1016/j.semnephrol.2017.09.002.
    1. Kancir AS, Pleckaitiene L, Hansen TB, Ekelof NP, Pedersen EB. Lack of nephrotoxicity by 6% hydroxyethyl starch 130/0.4 during hip arthroplasty: a randomized controlled trial. Anesthesiology. 2014;121(5):948–958. doi: 10.1097/ALN.0000000000000413.
    1. Mose FH, Jörgensen AN, Vrist MH, Ekelöf NP, Pedersen EB, Bech JN. Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial. BMC Nephrol. 2019;20(1):200. doi: 10.1186/s12882-019-1342-x.
    1. Jensen JM, Mose FH, Bech JN, Nielsen S, Pedersen EB. Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney. BMC Nephrol. 2013;14(1):202. doi: 10.1186/1471-2369-14-202.
    1. Jensen JM, Mose FH, Kulik AE, Bech JN, Fenton RA, Pedersen EB. Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls. BMC Nephrol. 2014;15(1):101. doi: 10.1186/1471-2369-15-101.
    1. Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol. 2001;280(5):F860–F867. doi: 10.1152/ajprenal.2001.280.5.F860.
    1. Al Therwani S, Mose FH, Jensen JM, Bech JN, Pedersen EB. Effect of vasopressin antagonism on renal handling of sodium and water and central and brachial blood pressure during inhibition of the nitric oxide system in healthy subjects. BMC Nephrol. 2014;15(1):100. doi: 10.1186/1471-2369-15-100.
    1. Pedersen EB, Danielsen H, Spencer ES. Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol. 1984;26(5):543–547. doi: 10.1007/BF00543482.
    1. Frank Holden M, Oczachowska-Kulik AE, Fenton RA, Bech JN. Effect of furosemide on body composition and urinary proteins that mediate tubular sodium and sodium transport-A randomized controlled trial. Physiol Rep. 2021;8(24):e14653.
    1. Kawano-Dourado L, Zampieri FG, Azevedo LCP, Correa TD, Figueiro M, Semler MW, et al. Low- versus high-chloride content intravenous solutions for critically ill and perioperative adult patients: a systematic review and meta-analysis. Anesth Analg. 2018;126(2):513–521. doi: 10.1213/ANE.0000000000002641.
    1. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. Jama. 2012;308(15):1566–1572. doi: 10.1001/jama.2012.13356.
    1. Shaw AD, Schermer CR, Lobo DN, Munson SH, Khangulov V, Hayashida DK, Kellum JA. Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome. Crit Care. 2015;19(1):334. doi: 10.1186/s13054-015-1045-z.
    1. Waters JH, Gottlieb A, Schoenwald P, Popovich MJ, Sprung J, Nelson DR. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg. 2001;93(4):817–822. doi: 10.1097/00000539-200110000-00004.
    1. Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R, SPLIT Investigators, ANZICS CTG Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. Jama. 2015;314(16):1701–1710. doi: 10.1001/jama.2015.12334.
    1. Krajewski ML, Raghunathan K, Paluszkiewicz SM, Schermer CR, Shaw AD. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg. 2015;102(1):24–36. doi: 10.1002/bjs.9651.
    1. Zampieri FG, Ranzani OT, Azevedo LC, Martins ID, Kellum JA, Liborio AB. Lactated ringer is associated with reduced mortality and less acute kidney injury in critically ill patients: a retrospective cohort analysis. Crit Care Med. 2016;44(12):2163–2170. doi: 10.1097/CCM.0000000000001948.
    1. Funke BE, Jackson KE, Self WH, Collins SP, Saunders CT, Wang L, et al. Effect of balanced crystalloids versus saline on urinary biomarkers of acute kidney injury in critically ill adults. BMC Nephrol. 2021;22(1):54. doi: 10.1186/s12882-021-02236-x.
    1. Young JB, Utter GH, Schermer CR, Galante JM, Phan HH, Yang Y, Anderson BA, Scherer LA. Saline versus plasma-Lyte a in initial resuscitation of trauma patients: a randomized trial. Ann Surg. 2014;259(2):255–262. doi: 10.1097/SLA.0b013e318295feba.
    1. Smith CA, Gosselin RC, Utter GH, Galante JM, Young JB, Scherer LA, Schermer CR. Does saline resuscitation affect mechanisms of coagulopathy in critically ill trauma patients? An exploratory analysis. Blood Coagul Fibrinolysis. 2015;26(3):250–254. doi: 10.1097/MBC.0000000000000154.
    1. Kim SY, Huh KH, Lee JR, Kim SH, Jeong SH, Choi YS. Comparison of the effects of normal saline versus Plasmalyte on acid-base balance during living donor kidney transplantation using the Stewart and base excess methods. Transplant Proc. 2013;45(6):2191–2196. doi: 10.1016/j.transproceed.2013.02.124.
    1. Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, Wang L, Byrne DW, Shaw AD, Bernard GR, Rice TW, Bernard GR, Semler MW, Noto MJ, Rice TW, Byrne DW, Domenico HJ, Wang L, Wanderer JP, Ehrenfeld JM, Shaw AD, Hernandez A, Kumar AB, Self WH, Siew ED, Dunlap DF, Stollings JL, Sullivan M, Knostman M, Mulherin DP, Hargrove FR, Janz DR, Strawbridge S. Balanced crystalloids versus saline in the intensive care unit. The SALT randomized trial. Am J Respir Crit Care Med. 2017;195(10):1362–1372. doi: 10.1164/rccm.201607-1345OC.
    1. Burdett E, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, Grocott MP, et al. Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev. 2012;12:Cd004089.
    1. Soliman KM, Campbell RC, Fulop T, Goddard T, Pisoni R. Acute kidney injury in subjects with chronic kidney disease undergoing Total joint Arthroplasty. Am J Med Sci. 2019;358(1):45–50. doi: 10.1016/j.amjms.2019.04.002.
    1. Maheshwari K, Turan A, Makarova N, Ma C, Esa WAS, Ruetzler K, Barsoum S, Kuhel AG, Ritchey MR, Higuera-Rueda C, Kopyeva T, Stocchi L, Essber H, Cohen B, Suleiman I, Bajracharya GR, Chelnick D, Mascha EJ, Kurz A, Sessler DI. Saline versus lactated Ringer's solution: the saline or lactated Ringer's (SOLAR) trial. Anesthesiology. 2020;132(4):614–624. doi: 10.1097/ALN.0000000000003130.
    1. Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, Stollings JL, Kumar AB, Hughes CG, Hernandez A, Guillamondegui OD, May AK, Weavind L, Casey JD, Siew ED, Shaw AD, Bernard GR, Rice TW, SMART Investigators and the Pragmatic Critical Care Research Group Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378(9):829–839. doi: 10.1056/NEJMoa1711584.
    1. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to plasma-Lyte. Ann Surg. 2012;255(5):821–829. doi: 10.1097/SLA.0b013e31825074f5.
    1. Volta CA, Trentini A, Farabegoli L, Manfrinato MC, Alvisi V, Dallocchio F, Marangoni E, Alvisi R, Bellini T. Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. J Inflamm (Lond) 2013;10(1):29. doi: 10.1186/1476-9255-10-29.
    1. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008;52(3):595–605. doi: 10.1053/j.ajkd.2008.01.020.
    1. Schiffl H, Lang SM. Update on biomarkers of acute kidney injury: moving closer to clinical impact? Mol Diagn Ther. 2012;16(4):199–207. doi: 10.1007/BF03262209.
    1. Xue W, Xie Y, Wang Q, Xu W, Mou S, Ni Z. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient. Nephrology (Carlton) 2014;19(4):186–194. doi: 10.1111/nep.12173.
    1. Weinberg L, Collins N, Van Mourik K, Tan C, Bellomo R. Plasma-Lyte 148: a clinical review. World J Crit Care Med. 2016;5(4):235–250. doi: 10.5492/wjccm.v5.i4.235.
    1. Traverso LW, Lee WP, Langford MJ. Fluid resuscitation after an otherwise fatal hemorrhage: I. Crystalloid solutions J Trauma. 1986;26(2):168–175. doi: 10.1097/00005373-198602000-00014.
    1. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest. 1999;104(7):R19–R23. doi: 10.1172/JCI7840.

Source: PubMed

3
Předplatit